美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Prana生物工艺

2.06

+0.0000

成交量：- -

成交额：- -

市值：1,948.14万

市盈率：-2.61

高：2.06

开：2.06

低：2.06

收：2.06

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Prana生物工艺

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.pranabio.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Prana Biotechnology 's platform technology is focused on developing treatments for neurodegenerative diseases with the financial support of various grants and private equity.The primary application of Co.'s platform is Alzheimer's Disease.

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"澳洲华人首选美澳港股一站式交易平台 | 老虎证券","description":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","keywords":"老虎证券,老虎证券澳洲,老虎证券股票,老虎证券开户,老虎证券app,tigertrade老虎证券,股票,asx美股,炒股,券商,澳洲股票交易,澳大利亚炒股","social":{"ogDescription":"澳、美、港、A股、ETF、期权一站式在线交易，超低佣金，新手也能轻松开启投资。在老虎证券， 1 美元起投资美股，24/5 无时差交易美股，澳大利亚华人信赖的在线炒股平台。","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PRAN/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"PRAN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRAN\",,,,,undefined,":{"symbol":"PRAN","market":"US","secType":"STK","nameCN":"Prana生物工艺","latestPrice":2.0597,"timestamp":1554753599999,"preClose":2.0597,"halted":8,"volume":0,"delay":0,"floatShares":8548886,"shares":9458349,"eps":-0.789921,"marketStatus":"交易中","change":0,"latestTime":"04-30 11:56:24 EDT","open":2.0597,"high":2.0597,"low":2.0597,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.789921,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746043200000},"marketStatusCode":2,"symbolChange":{"newSymbol":"ATHE","executeDate":"2019-04-09"},"adr":1,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.0597,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PRAN\",,,,,undefined,":{"symbol":"PRAN","floatShares":8548886,"roa":"--","roe":"--","lyrEps":-0.68787,"shares":9458349,"dividePrice":0,"high":2.0597,"amplitude":0,"preClose":2.0597,"low":2.0597,"week52Low":1.0854,"pbRate":"2.79","week52High":2.91,"institutionHeld":0.002,"latestPrice":2.0597,"eps":-0.789921,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.789921,"open":2.0597},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.pranabio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0513},{"period":"1month","weight":-0.0024},{"period":"3month","weight":-0.0789},{"period":"6month","weight":-0.0252},{"period":"1year","weight":0.0868},{"period":"ytd","weight":-0.0542}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prana Biotechnology 's platform technology is focused on developing treatments for neurodegenerative diseases with the financial support of various grants and private equity.The primary application of Co.'s platform is Alzheimer's Disease.","exchange":"NASDAQ","name":"Prana生物工艺","nameEN":"Prana Biotechnology"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PRAN\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PRAN\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PRAN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PRAN\",market:\"US\",delay:false,,,undefined,":{}}}